Cargando…

Efficacy and tolerability of benzalkonium chloride-free travoprost in glaucoma patients switched from benzalkonium chloride-preserved latanoprost or bimatoprost

INTRODUCTION: The preservative benzalkonium chloride (BAK) is used to preserve several topical, intraocular pressure (IOP)-lowering glaucoma medications but can cause tolerability concerns that may lead to decreased adherence to treatment and ultimately diminish the effectiveness of IOP control. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Feijoo, Julian, Muñoz-Negrete, Francisco J, Hubatsch, Douglas A, Rossi, Gemma C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085282/ https://www.ncbi.nlm.nih.gov/pubmed/27799736 http://dx.doi.org/10.2147/OPTH.S112711

Ejemplares similares

Effect of benzalkonium chloride–free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study
por: Lopes, Joao F., et al.
Publicado: (2015)

Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost
por: Tokuda, Naoto, et al.
Publicado: (2017)

Effectiveness of ophthalmic solution preservatives: a comparison of latanoprost with 0.02% benzalkonium chloride and travoprost with the sofZia preservative system
por: Ryan, Gerard, et al.
Publicado: (2011)

Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma
por: Walimbe, Tejaswini, et al.
Publicado: (2016)

Aspergilli Response to Benzalkonium Chloride and Novel-Synthesized Fullerenol/Benzalkonium Chloride Nanocomposite
por: Unković, Nikola, et al.
Publicado: (2015)

Noninferiority Study Comparing Latanoprost 0.005% Without Versus With Benzalkonium Chloride in Open-Angle Glaucoma or Ocular Hypertension
por: Wirta, David, et al.
Publicado: (2022)

Physiochemical Properties and Cytotoxicity of a Benzalkonium Chloride-Free, Micellar Emulsion Ophthalmic Formulation of Latanoprost
por: Halder, Arindam, et al.
Publicado: (2020)

Treatment persistence and cost-effectiveness of latanoprost/latanoprost–timolol, bimatoprost/bimatoprost–timolol, and travoprost/travoprost–timolol in glaucoma: an analysis based on the United Kingdom general practitioner research database
por: Lafuma, Antoine, et al.
Publicado: (2011)

Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension
por: Bhagat, Purvi, et al.
Publicado: (2014)

Generic benzalkonium chloride‐preserved travoprost eye drops are not identical to the branded polyquarternium‐1‐preserved travoprost eye drop: Effect on cultured human conjunctival goblet cells and their physicochemical properties
por: Hedengran, Anne, et al.
Publicado: (2022)

Controversy: Is Benzalkonium Chloride Necessary in Antiglaucoma Drops?
por: Louati, Y, et al.
Publicado: (2012)

Allergic contact dermatitis to dorzolamide and benzalkonium chloride
por: Orsini, Diego, et al.
Publicado: (2018)

Ocular benzalkonium chloride exposure: problems and solutions
por: Goldstein, Michael H., et al.
Publicado: (2021)

Open-Label Extension Study Comparing Latanoprost 0.005% Without vs With Benzalkonium Chloride in Open-Angle Glaucoma or Ocular Hypertension
por: Shen Lee, Bridgitte, et al.
Publicado: (2022)

Ocular Tolerability of Bimatoprost 0.1 mg/mL Preservative-Free versus Bimatoprost 0.1 mg/mL with Benzalkonium Chloride or Bimatoprost 0.3 mg/mL Preservative-Free in Patients with Primary Open-Angle Glaucoma
por: Filippelli, Mariaelena, et al.
Publicado: (2022)

Impact of benzalkonium chloride, benzethonium chloride and chloroxylenol on bacterial antimicrobial resistance
por: Maillard, Jean‐Yves
Publicado: (2022)

Preservative-Free versus Benzalkonium Chloride–Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial
por: Bacharach, Jason, et al.
Publicado: (2023)

Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells
por: Ammar, David A., et al.
Publicado: (2011)

Ocular Toxicity of Benzalkonium Chloride Homologs Compared with Their Mixtures
por: Okahara, Akihiko, et al.
Publicado: (2013)

Intrinsic Resistance of Burkholderia cepacia Complex to Benzalkonium Chloride
por: Ahn, Youngbeom, et al.
Publicado: (2016)

Is it time for a moratorium on the use of benzalkonium chloride in eyedrops?
por: D'andrea, Luca, et al.
Publicado: (2022)

Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride
por: Liang, H, et al.
Publicado: (2008)

Preservative-Free versus Benzalkonium Chloride–Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial [Corrigendum]
Publicado: (2023)

The Hormetic Effect Observed for Benzalkonium Chloride and Didecyldimethylammonium Chloride in Serratia sp. HRI
por: McCarlie, Samantha J., et al.
Publicado: (2023)

Therapeutic Effects of Sodium Hyaluronate on Ocular Surface Damage Induced by Benzalkonium Chloride Preserved Anti-glaucoma Medications
por: Liu, Xing, et al.
Publicado: (2015)

Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops
por: Rosin, Lauren M, et al.
Publicado: (2013)

Corneal Alternations Induced by Topical Application of Benzalkonium Chloride in Rabbit
por: Chen, Wensheng, et al.
Publicado: (2011)

Benzalkonium Chloride Induced Bronchoconstriction in Patients with Stable Bronchial Asthma
por: Lee, Byoung Hoon, et al.
Publicado: (2007)

Effects of Benzalkonium Chloride on THP-1 Differentiated Macrophages In Vitro
por: Michée, Sylvain, et al.
Publicado: (2013)

Reduction of cytotoxicity of benzalkonium chloride and octenidine by Brilliant Blue G
por: Bartok, Melinda, et al.
Publicado: (2015)

Nasal Mucosal Dysplasia Induced by Topical Corticosteroids with Benzalkonium Chloride
por: Tamer, Funda, et al.
Publicado: (2018)

Benzalkonium Chloride Induces a VBNC State in Listeria monocytogenes
por: Noll, Matthias, et al.
Publicado: (2020)

Benzalkonium chloride antagonises aminoglycoside antibiotics and promotes evolution of resistance
por: Short, Francesca L, et al.
Publicado: (2021)

Corneal Alterations Induced by Topical Application of Commercial Latanoprost, Travoprost and Bimatoprost in Rabbit
por: Chen, Wensheng, et al.
Publicado: (2014)

Analysis of the Responsiveness of Latanoprost, Travoprost, Bimatoprost, and Tafluprost in the Treatment of OAG/OHT Patients
por: Cai, Ziyan, et al.
Publicado: (2021)

Tn6188 - A Novel Transposon in Listeria monocytogenes Responsible for Tolerance to Benzalkonium Chloride
por: Müller, Anneliese, et al.
Publicado: (2013)

Persistence against benzalkonium chloride promotes rapid evolution of tolerance during periodic disinfection
por: Nordholt, Niclas, et al.
Publicado: (2021)

Comparison of Efficacy and Ocular Surface Disease Index Score between Bimatoprost, Latanoprost, Travoprost, and Tafluprost in Glaucoma Patients
por: El Hajj Moussa, Wissam Georges, et al.
Publicado: (2018)

Cytotoxicity of prostaglandin analog eye drops preserved with benzalkonium chloride in multiple corneoconjunctival cell lines
por: Ayaki, Masahiko, et al.
Publicado: (2010)

Impact of benzalkonium chloride-preserved and preservative-free latanoprost eye drops on cultured human conjunctival goblet cells upon acute exposure and differences in physicochemical properties of the eye drops
por: Müllertz, Olivia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mt7t0ksn3km3793aops63ai1i8